Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Zaleski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Assay and Drug Development Technologies|November 27, 2019
Systematically Prioritizing Candidates in Genome-Based Drug RepurposingAnup P Challa, Robert R Lavieri, Judith T Lewis, et al.
Future Medicinal Chemistry|May 24, 2018
Advocating for mutually beneficial access to shelved compoundsJill M Pulley, Rebecca N Jerome, Jana K Shirey-Rice, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Journal of Reproductive Biotechnology & Fertility|January 15, 2019
The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTAJodell E Linder, Kisha Batey, Rebecca Johnston, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Assay and Drug Development Technologies|November 27, 2019
Systematically Prioritizing Candidates in Genome-Based Drug RepurposingAnup P Challa, Robert R Lavieri, Judith T Lewis, et al.
Future Medicinal Chemistry|May 24, 2018
Advocating for mutually beneficial access to shelved compoundsJill M Pulley, Rebecca N Jerome, Jana K Shirey-Rice, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Journal of Reproductive Biotechnology & Fertility|January 15, 2019
The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTAJodell E Linder, Kisha Batey, Rebecca Johnston, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 1